CoQ10 100 mg plus BioPerine

CoQ10 100 mg plus BioPerine

Lake Avenue Nutrition4.8 (7,041 ratings)
Format:Softgel Quantity: 365 Softgel(s) · 365 servings
Goals
$37.00 $0.10 per serving

Product analysis

69 out of 100

CoQ10 100 mg plus BioPerine offers good value for CoQ10 and may support blood-vessel function in some people. The added black pepper may help absorption, though that does not establish an extra health benefit.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality36

The CoQ10 is identified as ubiquinone, but the available details do not establish an advantage in form quality. The black-pepper form is not fully specified, which also limits comparison.

Ingredient Transparency81

The amount of each active ingredient is stated, and CoQ10 is identified as ubiquinone. The black-pepper component is less fully described, making it harder to compare its preparation.

Value For Money88

CoQ10 offers favorable value at the full serving price. The value of the black-pepper addition remains uncertain.

Customer Satisfaction92

Customer ratings indicate very high satisfaction. A large pool of customer ratings provides a broader picture of satisfaction.

Product Focus70

The short formula concentrates on CoQ10 and its connection to blood-vessel function and cellular energy. Broader energy and aging benefits remain less certain.

Format
Softgel
Container
365 Softgel(s)
Per serving
$0.10
Customer rating
4.8 · 7,041 ratings
Report analysis

Goals

Heart Health
Impact
Highest effect
A- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 may offer limited support for blood-vessel function and blood pressure in selected populations. The declared conventional CoQ10 is compared with ordinary oral CoQ10 exposure, without assuming a delivery advantage. The supplied findings concern vascular measurements, not established prevention of heart attacks.

How this product is rated for Heart Health

Ingredient fit86

Coenzyme Q10 provides the product's focused connection to heart health. Its serving receives partial exposure recognition.
Goal fit
Coenzyme Q10 is the main relevant active; the product is also linked to other goals.
Dose adequacy
Coenzyme Q10's serving has partial exposure recognition; the reference comparison does not predict the size of a benefit.

Pathways53

The supported connection is chiefly blood-vessel function. It does not cover a broad range of heart-health mechanisms.
Depth
The strongest saved connection is endothelial nitric-oxide function, reflecting the included ingredients and their declared amounts.
Breadth
One mechanism reaches the saved coverage threshold, so the support remains focused.

Evidence98

The declared CoQ10 preparation matches the saved oral preparation criteria. Human findings support limited vascular effects in selected populations.
Evidence strength
CoQ10 has human vascular findings in selected populations; these do not establish routine event prevention.
Studied preparation
Declared conventional CoQ10 meets the saved preparation criteria; this does not establish superiority over other forms.

Formulation logic100

The counted ingredients have no unmet partner requirement or matched formulation conflict. This does not imply an extra benefit from combining ingredients.
Partner coverage
The counted ingredients can contribute without an additional required partner, or have the required partner present.
Conflicts
No specified stimulant or high-sodium conflict was matched in the supplied product facts.
Effective doses
Coenzyme Q10 clears the saved minimum exposure threshold, which is not proof of a clinically effective dose.
Study evidence
Energy
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 participates in cellular energy production, and this product declares 100 mg ubiquinone per serving. Its fatigue evidence is limited and exercise-specific: the small supplied trial reported improvements at 300 mg/day, above this serving. Black pepper is included as an absorption partner without a separate energy contribution or demonstrated added fatigue benefit. Serving amount does not establish the trial regimen.

How this product is rated for Energy

Ingredient fit73

The relevant ingredients are focused on this goal, while the product also has links to other goals. Declared amounts receive partial recognition overall; the comparison does not establish a clinically effective fatigue dose.
Goal fit
The relevant ingredients are focused on this goal, while the product also has links to other goals.
Dose adequacy
Declared amounts receive partial recognition overall; the comparison does not establish a clinically effective fatigue dose.

Pathways17

The contribution is confined to mitochondrial energy production.
Depth
The contribution is confined to mitochondrial energy production.
Breadth
The mitochondrial contribution remains below the breadth threshold, and no other pathway qualifies.

Evidence84

Coenzyme Q-10 leads the saved evidence finding. The counted preparations receive recognition, subject to their specific population and outcome limitations.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; its practical relevance depends on the specific population and outcome described.
Studied preparation
The counted preparation or preparations receive recognition; matching a preparation alone does not establish the same regimen or benefit.

Formulation logic100

CoQ10 can contribute independently; black pepper is present as an absorption partner without standalone energy credit. No configured conflict was matched.
Partner coverage
CoQ10 can contribute independently; black pepper is present as an absorption partner without standalone energy credit.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All counted ingredients meet the amount inclusion criterion, which is distinct from a clinically proven benefit threshold.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg supports normal mitochondrial energy production and antioxidant processes. A small trial of a specific water-soluble CoQ10 preparation found selected improvements in skin wrinkles and smoothness; that finding does not show that generic CoQ10 extends life. Piperine may increase absorption, but that alone does not establish an aging benefit.

How this product is rated for Longevity

Ingredient fit73

The relevant ingredient gives the formula a clear focus on the reviewed aging-related functions. Ingredient amounts provide a partial match to the saved exposure comparisons.
Goal fit
The relevant ingredient gives the formula a clear focus on the reviewed aging-related functions.
Dose adequacy
Ingredient amounts provide a partial match to the saved exposure comparisons.

Pathways10

The leading mechanism in the saved assessment is mitochondrial energy production. None of the three target mechanisms reaches the saved coverage threshold.
Depth
The leading mechanism in the saved assessment is mitochondrial energy production.
Breadth
None of the three target mechanisms reaches the saved coverage threshold.

Evidence30

Coenzyme Q-10 leads the saved evidence finding; that comparison does not establish longer life. Preparation matching is limited for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; that comparison does not establish longer life.
Studied preparation
Preparation matching is limited for Coenzyme Q-10.

Formulation logic100

The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was found in the supplied assessment. 1 of 1 counted ingredients reach the saved minimum amount criterion.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
1 of 1 counted ingredients reach the saved minimum amount criterion.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 in its ubiquinone form relates to oxidative and mitochondrial stress. A small trial in statin-treated people with coronary artery disease found a change in one inflammatory marker, while others were unchanged; this does not establish routine clinical benefit. Its 100 mg per serving is below the reviewed 300 mg/day exposure.

How this product is rated for Inflammation

Ingredient fit66

The relevant ingredient is the focus of the declared active ingredients, although the product is linked to several goals. The ubiquinone serving falls below the reviewed 300 mg/day regimen, limiting the exposure match.
Goal fit
The relevant ingredient is the focus of the declared active ingredients, although the product is linked to several goals.
Dose adequacy
The ubiquinone serving falls below the reviewed 300 mg/day regimen, limiting the exposure match.

Pathways13

The strongest recorded connection is oxidative and mitochondrial stress, with limited coverage in the saved comparison. No route reaches the breadth threshold.
Depth
The strongest recorded connection is oxidative and mitochondrial stress, with limited coverage in the saved comparison.
Breadth
No pathway reaches the saved comparison’s breadth threshold, so the ingredient’s connection remains narrow.

Evidence93

Ubiquinone supplies the strongest recorded human-evidence contribution. The reviewed finding concerns selected inflammatory markers in statin-treated coronary artery disease.
Evidence strength
Ubiquinone supplies the strongest recorded human-evidence contribution.
Studied preparation
The counted preparations match those recognized in the saved comparison; this does not establish equivalent clinical results.

Formulation logic100

Partner requirements are met and no configured conflict was recorded. The counted ingredients reach the saved amount threshold.
Partner coverage
The counted ingredients can stand alone or have the partners required by the saved comparison; no added benefit from combining them is established.
Conflicts
No configured ingredient conflict was recorded; this finding is limited to the interactions checked.
Effective doses
The counted ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 participates in cellular energy production, but this normal role does not establish that supplementation increases whole-body energy use. The supplied findings do not show a lasting metabolism boost or an advantage from a particular CoQ10 form.

How this product is rated for Metabolism Support

Ingredient fit73

CoQ10 accounts for the counted contribution, with its declared serving amount determining the comparison.
Goal fit
CoQ10 supplies the counted goal-related contribution.
Dose adequacy
The counted amounts partly meet the saved references; unknown amounts cannot establish a contribution comparable with studied exposures.

Pathways17

The main recorded contribution concerns mitochondrial energy and fat oxidation; this does not by itself demonstrate increased whole-body energy use.
Depth
The main recorded contribution concerns mitochondrial energy and fat oxidation; this does not by itself demonstrate increased whole-body energy use.
Breadth
No evaluated pathway reached the coverage criterion.

Evidence75

The saved evidence comparison accepts nutrient or cellular roles, while the supplied scientific context limits claims of increased energy expenditure.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison, but its physiological role or metabolic-marker findings do not establish a routine increase in energy expenditure.
Studied preparation
The counted preparations meet the saved preparation comparison; this does not prove a particular form raises metabolic rate more effectively.

Formulation logic100

There are no unmet partner requirements or configured conflicts. The amount findings describe the counted ingredients, without establishing combined metabolic benefits.
Partner coverage
No counted ingredient has an unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was triggered.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not proof of increased metabolic rate.
Study evidence
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 has limited support for blood-pressure, lipid and vessel-lining markers in selected populations. This product supplies ubiquinone, but the supplied findings do not establish superiority of one CoQ10 form or prevention of cardiovascular events. Its saved connection concentrates on vessel-lining function. The declared amount qualifies for the saved comparison without establishing a matching daily study regimen.

How this product is rated for Cardiovascular Support

Ingredient fit86

CoQ10 is the relevant active and has a disclosed ubiquinone preparation.
Goal fit
The relevant active ingredients have no listed off-goal actives, although the product is linked to several goals.
Dose adequacy
CoQ10 meets the saved preparation-specific amount comparison.

Pathways53

Vessel-lining function is the sole area with substantial saved coverage.
Depth
Vessel-lining function is the strongest saved area.
Breadth
Only vessel-lining function reaches the saved coverage threshold.

Evidence88

CoQ10 has selected vascular-marker findings; general cardiovascular-event prevention is not established.
Evidence strength
CoQ10 leads the saved evidence finding, with limited marker support in selected populations.
Studied preparation
The saved finding accepts the ubiquinone preparation without establishing superiority over other CoQ10 forms.

Formulation logic100

The retained ingredients can stand alone, with no configured conflict and qualifying saved amounts.
Partner coverage
All retained ingredients either work alone or have their configured partner.
Conflicts
No configured conflict was found in the supplied facts.
Effective doses
The retained ingredient meets the saved amount threshold.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q-10 (Ubiquinone)
100 mg 67
Black Pepper fruit extract
5 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
C Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyA+ Value
A serving supplies 100 mg of CoQ10 as ubiquinone. The evaluation flags an additive of concern, but the supplied facts do not identify it.
How this ingredient is rated

Active Ingredient Quality & Bioavailability64

The CoQ10 is listed as ubiquinone. The evaluation records a BioPerine or black pepper extract claim; the supplied facts do not specify which.
Molecular Form: Ubiquinol vs. Ubiquinone
The CoQ10 is listed as ubiquinone.
Formulation & Absorption Enhancers
The evaluation records a BioPerine or black pepper extract claim; the supplied facts do not specify which.

Dose, Safety & Label Transparency53

The amount is recorded as 100 mg per serving. The evaluation flags an additive of concern, but the supplied facts do not identify it.
Clinical Dosage Alignment
The serving provides 100 mg of CoQ10.
Label Transparency & Fillers
The amount is recorded as 100 mg per serving. The evaluation flags an additive of concern, but the supplied facts do not identify it.

Value100

At the whole-product serving price, the cost works out to about $0.10 per 100 mg of CoQ10.
Price Per Effective Serving
At the whole-product serving price, the cost works out to about $0.10 per 100 mg of CoQ10.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10